FDA found Bacillus cereus and other quality lapses at Medline's Waukegan drug plant; the agency ordered independent risk assessments and remediation timelines.

The FTC is requiring Ascension to divest seven ambulatory surgery centers in five metros before its $3.9B AmSurg acquisition can close.

An early Penn Medicine trial suggests CAR‑T immunotherapy may be adapted for kidney failure, offering a new path for transplant and fibrosis patients while important safety questions remain.